Copyright: ©Author(s) 2026.
World J Clin Oncol. Mar 24, 2026; 17(3): 116534
Published online Mar 24, 2026. doi: 10.5306/wjco.v17.i3.116534
Published online Mar 24, 2026. doi: 10.5306/wjco.v17.i3.116534
Table 3 Effects and specific mechanisms of single herbs and their ingredients for the treatment of gastric cancer
| Herb | Active component/extract | Functions | Clinical stage | Experimental model | Effect | Specific mechanism | Ref. |
| Peel and pulp of citrus grandis, citrus paradise and orange (Zhike, Chenpi) | Naringin | Anti-tumor | GC | In vitro (MGC803 and MKN45 GC cells). In vivo (BALB/c female nude mice) | Block the cell-cycle of GC cells | Induce cancer cell apoptosis, and inhibit the epithelial mesenchymal transition process by inhibiting the PI3K-AKT/Zeb1 pathway | [66] |
| Poria cocos (Fuling) | Pachymic acid | Anti-tumor | GC | In vitro (SGC-7901, AGS, and GES-1). In vivo (BALB/c nude mice) | Ferroptosis in GC cells | Suppressing the PDGFRB-mediated PI3K/AKT pathway | [67] |
| Poria acid | In vitro (AGS and MKN-28) | Inhibit the invasion and metastasis of GC cells | Inhibit the EMT process and expressions of metastasis-related proteins matrix metalloproteinase in GC cells | [68] | |||
| Cimicifugae Rhizoma (Shengma) | Cimifugin | Anti-tumor | GC | In vitro (MKN28) | Inhibits GC cell proliferation, invasion, and migration | Interacts with AKR1C2, MAOB and PDE2A to modulate various metabolic pathways | [69] |
| the roots of Plumbago zeylanica (Banlangen) | Plumbagin | Anti-tumor | GC | In vitro (SGC-7901 cells) | Inhibits cell apoptosis in human GC cells | Suppressed the expression of BAX, BCL-2, pro-caspase-3, and cleaved-caspase-3; restrained the expression and phosphorylation of STAT3 and decreased the phosphorylation of AKT1 | [70] |
| Eremias multiocellata | N/A | Removing blood stasis, eliminating nodules | Cisplatin-resistant GC | In vitro (MKN45/DDP). In vivo (BALB/c nude mice) | Reversing DDP resistance and increasing the sensitivity of gastric cancer drug-resistant cells to DDP | Regulating the NF-κB/Snail signaling pathway, PI3K/AKT/mTOR signaling pathway, and the expression of drug resistance-related proteins and genes | [112] |
| Salvia miltiorrhiza Bunge (Danshen) | Diterpenoid tanshinones | Activating blood circulation and removing blood stasis | GC | In vitro (SGC-7901, HUVECs). In vivo (BALB/c-nu nude mice) | Inhibit tumor growth and angiogenesis | Affecting the expression of the angiogenic factor VEGF through the PI3K/AKT/mTOR pathway | [73] |
| Celastrus orbiculatus Thunb (Leigongteng) | Triptonoterpene | Anti-metastasis, anti-tumor | Advanced GC | In vitro (BGC-823, MKN-28) | Inhibit the migration and invasion of GC cells | Inhibit the changes in EMT-related and invasion and metastasis-related proteins | [71] |
| In vitro (BGC-823 and AGS). In vivo (nude mice) | Inhibit the metastasis and EMT of GC cells | Inhibited the remodeling of the actin skeleton of gastriccancer cells by promoting the degradation of CFL1 | [72] | ||||
| Trametes robiniophila Murr. (Huaier) | Huaier n-butanol extract | Anti-metastasis, anti-tumor | Advanced GC | In vitro (GES-1, MGC803, MKN74, AZ-521, and MKN28). In vivo (nude mice) | Inhibits GC growth and hepatic metastasis | Inhibiting the syntenin/STAT3 signaling pathway and reversing EMT | [76] |
| Rhizoma coptidis (Chaihu) | Berberine | Anti-inflammatory, anti-tumor | Advanced GC | In vitro (MKN-45 and HGC-27 and GES-1). In vivo (male BALB/C nude mice) | Inhibits GC cell proliferation | Modulating the signaling pathways related to IL-6/JAK2/STAT3 | [77] |
| Paeonia suffruticosa Andr. (Mudanpi) | Paeonol | Anti-tumor, anti-inflammation, immune regulation | Apatinib-resistant GC | In vitro (BGC-823 and MGC-80). In vivo (female BALB/C nude mice) | Inhibit the malignancy of Apatinib-resistant GC cells | Regulating the LINC00665/miR-665/MAPK1 axis | [81] |
| Brucea javanica (Yadanzi) | Brusatol | Antitumor | Advanced GC | In vitro (SGC-7901) | Suppress GC cell proliferation, migration, invasion, and EMT formation | Inhibit LPS-induced EMT via the deactivation of the PI3K/AKT/NF-кB signaling pathway | [83] |
| Curcuma (wenyujin) | β-Elemene | Anti-metastasis, anti-tumor | Multidrug resistant GC | In vitro (SGC7901, SGC7901/ADR). In vivo (male BALB/C nude mice) | Inhibits the metastasis of multidrug resistant GC cells | Modulating the miR-1323/Cbl-b/EGFR signaling axis | [86] |
| Highly toxic beetles of the family Meloidae | Cantharidin | Anti-metastasis, anti-tumor | Advanced GC | In vitro (MGC803 and BGC823) | Suppress GC cell growth and migration/invasion | Inhibited the activation of the PI3K/AKT signaling pathway by downregulating CCAT1 targeting | [89] |
| Arachis hypogaea Linn. and Vitis vinifera Linn. | Resveratrol | Anti-metastasis, anti-tumor | Advanced GC | In vitro (SGC7901, BGC823 and GES1) | Suppress the invasion and migration of human GC cells | Inhibition of MALAT1-mediated epithelial-to-mesenchymal transition | [92] |
| Interleukin-6 induced GC metastasis | In vitro (SGC-7901). In vivo (male NOD/SCID mice) | Prevent the IL-6 induced GC metastasis | Block the IL-6 induced invasion through the blocking of Raf-MAPK signaling pathway | [93] | |||
| Radix Angelica Sinensis (danggui) | N-butylidenephthalide | Anti-metastasis, anti-tumor | Advanced GC | In vitro (AGS, NCI-N87 and TSGH-9201). In vivo (NOD-SCID mice) | Inhibit proliferation and induces mitochondrial-dependent apoptosis in GC cells | Activation of mitochondria-intrinsic pathway and induced the REDD1 expression leading to mTOR signal pathway inhibition in GC cells | [94] |
| Venenum Bufonis (Chan Su) | Bufalin | Anti-invasion, anti-metastasis | Advanced GC | In vitro (AGS). In vivo (male BALB/c mice) | Arrests GC invasion and metastasis | Down-regulation of the Wnt/β-catenin signaling pathway, followed by the inhibition of ASCL2 expression and EMT | [95] |
| Ginseng | Ginsenoside Rg3 | Anti-metastasis, anti-tumor | Metastatic GC | In vitro (NUGC-4). In vivo (female BALB/c mice) | Inhibite tumor growth and reduced lymphatic metastasis | Suppress expression of VEGF-C, VEGF-D and VEGFR-3 | [96] |
- Citation: Zhao XF, Zhang YJ, Wang SL, Lian FM, Liu Z. Adjuvant role of traditional Chinese medicine in postoperative gastric cancer. World J Clin Oncol 2026; 17(3): 116534
- URL: https://www.wjgnet.com/2218-4333/full/v17/i3/116534.htm
- DOI: https://dx.doi.org/10.5306/wjco.v17.i3.116534